Skip to main content
. 2019 Mar 12;10(21):2041–2054. doi: 10.18632/oncotarget.26724

Figure 2. Depletion of CD164 expression decreases proliferation in GBM cells.

Figure 2

(A) Western blot verification of CD164 downregulation after transfection of U87MG and U118MG cells with siCD164. α-actinin was used as loading control. (B) Cell proliferation results. Cell numbers were counted at the indicated time points. (C) BrdU incorporation assay results. M1, BrdU-negative cells; M2, BrdU-positive cells. Cells not exposed to BrdU were used as blank controls. Results are presented as the mean ± SD of triplicate samples from three independent experiments (*p < 0.05, **p < 0.01, ***p < 0.001).